RT Book, Section
A1 Williams, Saralyn R.
A1 Thurman, R. Jason
A2 Knoop, Kevin J.
A2 Stack, Lawrence B.
A2 Storrow, Alan B.
A2 Thurman, R. Jason
SR Print(0)
ID 1181056801
T1 Poisoning by β-Blocker and Calcium Channel Blocker Agents
T2 The Atlas of Emergency Medicine, 5e
YR 2021
FD 2021
PB McGraw-Hill
PP New York, NY
SN 9781260134940
LK accessemergencymedicine.mhmedical.com/content.aspx?aid=1181056801
RD 2024/04/23
AB β-Blockers  and  calcium  channel  blockers  have  various  clinical  indications,  including  the  management  of  hypertension,  myocardial  infarction,  and  cardiac  dysrhythmias,  as  well  as  the  treatment  of  noncardiovascular  conditions  (eg,  glaucoma,  thyrotoxicosis,  migraine  headache  prophylaxis).  β-Blocking  agents  may  be  selective  for  B1-adrenergic  receptors  or  nonselective.  With  therapeutic  use,  the  commonly  available  calcium  channel  blockers  are  selective  for  the  membrane-bound  L-type  calcium  channel.  Inhibition  of  this  channel  prevents  influx  of  extracellular  calcium.